CytoSorb®use in LVAD patients –What are the benefits? Prof. Matthias Thielmann, Essen, Germany
Lee mas
Description Brand new data and publications - introduced and discussed by the author: Assoc. Prof. Endre Németh, Semmelweis University Budapest Moderation: Dr. Marijana Matejic-Spasic, CytoSorbents Europe GmbH
Lee mas
Update on CytoSorb® in Infective Endocarditis and other cardiovascular indications. Prof. Daniel Wendt, Essen/German
Lee mas
Removal of antithrombotics in Cardiac Surgery – Update of current knowledge Dr. Efthymios Deliargyris, Princeton/USA
Lee mas
Hemoadsorption in infective endocarditis and antithrombotic removal in the cardiosurgical setting: an update Prof. Dr. med. Daniel Wendt Update of the current literature Patient selection Cost effectiveness Outlook ..
Lee mas
Recording CytoSorbents Lunch Symposium at the EACTS 2022 Lunch Symposium at the EACTS 2022 October 7th 2022 Hemoadsorption with CytoSorb in high-risk cardiac surgery indications – new data 00:00 -..
Lee mas
Experiencia de uso de Cytosorb en cirugía cardíaca pediátrica
Lee mas
Chair: Roberto Lorusso, Maastricht,The Netherlands and Federico Pappalardo, Alessandria, Italy CytoSorb + ECMO in COVID-19: latest results from the Multicenter CTC Registry Awori Hayanga, Morgantown, USA Use of CytoSorb and..
Lee mas
About CytoSorb, Cardiac Surgery, COVID-19, ECMO, Intensive Care, Liver, Nephrology, Use and Application. Opening Lecture What we know and what we don’t know about Sepsis Manu Shankar-Hari, London/UK New Data and latest findings Chair: Didier Payen, Nice/France..
Lee mas